These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21547396)

  • 1. Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study.
    Le Rhun E; Taillibert S; Zairi F; Devos P; Pierret MF; Dubois F; Assaker R; Buisset E; Bonneterre J; Baranzelli MC
    J Neurooncol; 2011 Nov; 105(2):309-15. PubMed ID: 21547396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
    Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
    Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
    J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.
    Kim HK; Lee HS; Heo MH; Kim JY; Ahn JS; Im YH; Lee JI; Park YH
    Clin Breast Cancer; 2021 Aug; 21(4):e402-e414. PubMed ID: 33526378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations.
    Lee S; Ahn HK; Park YH; Nam DH; Lee JI; Park W; Choi DH; Huh SJ; Park KT; Ahn JS; Im YH
    Breast Cancer Res Treat; 2011 Oct; 129(3):809-17. PubMed ID: 21785952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
    Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE
    BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
    Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
    Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.
    Du C; Hong R; Shi Y; Yu X; Wang J
    J Neurooncol; 2013 Nov; 115(2):285-91. PubMed ID: 24000114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
    Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
    Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
    Le Rhun E; Kramar A; Salingue S; Girot M; Rodrigues I; Mailliez A; Zairi F; Bakhache E; Robin YM; Taillibert S; Dubois F; Bonneterre J; Chamberlain MC
    J Neurooncol; 2014 Mar; 117(1):117-24. PubMed ID: 24469852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM).
    Niwińska A; Pogoda K; Michalski W; Kunkiel M; Jagiełło-Gruszfeld A
    J Neurooncol; 2018 May; 138(1):191-198. PubMed ID: 29435818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
    Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
    J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
    Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.